Global Med Technologies(R), Inc. Prepares for First Sub-Saharan African Software Installation Global Med's Software to Manage Vein-to-Vein(R) Transfusion Cycle DENVER, April 21 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announces the kickoff, in May 2004, of its first sub-Saharan African implementation (with receipt of funds) of its Wyndgate Technologies ("Wyndgate") division's SafeTrace(R) donor management system and SafeTrace Tx(R)* transfusion management system. This marks the beginning of Global Med's foray into international markets where there are abundant opportunities to help underdeveloped countries upgrade their blood supply. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Blood centers are faced with blood shortages and an environment of possible contamination of the blood supply with blood-borne diseases, such as HIV, hepatitis, West Nile Virus, etc. These factors, especially the spread of HIV, are becoming drivers in the international market for blood center and transfusion services. Most blood banks and hospitals in sub-Saharan Africa utilize manual processes and maintain only manual records with little or no computer software or automation to help control the testing and safe release of blood and blood products. Wyndgate's donor and hospital transfusion information systems, with their comprehensive safety features, will help to enhance the quality of blood products distributed throughout sub-Saharan Africa by helping to ensure that only suitable blood products are released for transfusion. Potentially, this may help to decrease the transmission rate of HIV/AIDS through blood transfusions in sub-Saharan Africa, which in turn may ultimately help to save many lives. Mick Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc., stated, "This is truly a milestone for Global Med -- something that the management team always believed would happen and which has the potential to catapult the Company into many other countries to sell its medical software management systems." Dr. Ruxin continued, "This six-figure agreement in two small African cities, in one small African country, underscores the $100+ million dollar potential for Global Med in the international arena. Further, this is true testimony to the quality of our products and the professionalism and competency of our employees as we move forward into international markets. We are very excited by this opportunity and are looking to additional international sales in the not-too-distant future." Wyndgate has strategic marketing relationships with companies in the blood services products industry, such as McKesson Information Solutions, a division of McKesson Corporation, Siemens Medical Solutions Health Services Corporation, a multi-billion dollar Siemens Company, Sysmex InfoSystems America, Inc. (SIA), the Healthcare Solutions Division of Keane, Inc., Misys Healthcare Systems, and GE Medical Systems. Through these partnerships, Global Med is poised to take advantage of expanded market opportunities for its blood services management software. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. blood centers and transfusion services. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. *Patent Pending This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. AP Archive: http://photoarchive.ap.org PRN Photo Desk, photodesk@prnewswire.com http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE: Global Med Technologies, Inc. CONTACT: media, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, , or investors, Tom Marcinek, President and COO, +1-916-404-8413, , both of Wyndgate Technologies, for Global Med Technologies Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright